5397-64-8 Usage
Uses
Used in Pharmaceutical Industry:
3,6-DIHYDROXY-4-CHLOROPYRIDAZINE is used as a key intermediate in the synthesis of various pharmaceuticals for its potential to contribute to the development of new drugs. Its unique chemical structure allows for the creation of molecules with specific therapeutic properties, addressing unmet medical needs.
Used in Agrochemical Industry:
In the agrochemical sector, 3,6-DIHYDROXY-4-CHLOROPYRIDAZINE serves as a crucial component in the production of agrochemicals, including pesticides and herbicides. Its incorporation into these products can enhance their effectiveness in protecting crops and controlling pests, thereby contributing to increased agricultural productivity.
Used in Antiviral and Antibacterial Applications:
3,6-DIHYDROXY-4-CHLOROPYRIDAZINE is utilized in the research and development of antiviral and antibacterial agents due to its demonstrated biological activities. Its potential to inhibit viral and bacterial growth makes it a promising candidate for the creation of new treatments and preventive measures against infectious diseases.
Check Digit Verification of cas no
The CAS Registry Mumber 5397-64-8 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,3,9 and 7 respectively; the second part has 2 digits, 6 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 5397-64:
(6*5)+(5*3)+(4*9)+(3*7)+(2*6)+(1*4)=118
118 % 10 = 8
So 5397-64-8 is a valid CAS Registry Number.
InChI:InChI=1/C4H3ClN2O2/c5-2-1-3(8)6-7-4(2)9/h1H,(H,6,8)(H,7,9)
5397-64-8Relevant academic research and scientific papers
HETEROCYCLYC SULFONAMIDES HAVING EDG-I ANTAGONISTIC ACTIVITY
-
Page/Page column 182-183, (2008/12/05)
The invention relates to chemical compounds of formula (I), (Ia) and (Ib) or pharmaceutically acceptable salts thereof, which possess Edg-1 antagonistic activity and are accordingly useful for their anti-cancer activity and thus in methods of treatment of the human or animal body. The invention also relates to processes for the manufacture of said chemical compounds, to pharmaceutical compositions containing them and to their use in the manufacture of medicaments for use in the production of an anti-cancer effect in a warm-blooded animal, such as man.
Pyridotriazines and pyridopyridazines
-
Page 13, 16, (2010/01/31)
This invention relates to bicyclic heterocycles that inhibit cyclin-dependent kinase or tyrosine kinase enzymes, or both, and as such are useful to treat cell proliferative disorders such as angiogenesis, atherosclerosis, restenosis, and cancer as well as immunological disorders such as asthma, rheumatoid arthritis, autoimmune diabetes, and graft rejection associated with transplant surgery in mammals.
